Peptide-induced de novo bone formation after tooth extraction prevents alveolar bone loss in a murine tooth extraction model.
暂无分享,去创建一个
Y. Tabata | N. Wakabayashi | K. Aoki | R. Murali | T. Ono | Y. Shimizu | S. Mise‐Omata | Y. Arai
[1] N. Wakabayashi,et al. A threshold of mechanical strain intensity for the direct activation of osteoblast function exists in a murine maxilla loading model , 2016, Biomechanics and modeling in mechanobiology.
[2] N. Sims,et al. Is RANKL inhibition both anti-resorptive and anabolic in rheumatoid arthritis? , 2015, Arthritis Research & Therapy.
[3] N. Wakabayashi,et al. The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study , 2015, Arthritis Research & Therapy.
[4] J. Lindhe,et al. Ridge alterations following grafting of fresh extraction sockets in man. A randomized clinical trial. , 2015, Clinical oral implants research.
[5] H. Schliephake. Clinical efficacy of growth factors to enhance tissue repair in oral and maxillofacial reconstruction: a systematic review. , 2015, Clinical implant dentistry and related research.
[6] M. Bouxsein,et al. Cortical and trabecular load sharing in the human femoral neck. , 2015, Journal of biomechanics.
[7] T. Martin,et al. RANKL/OPG; Critical role in bone physiology , 2015, Reviews in Endocrine and Metabolic Disorders.
[8] L. Duong,et al. PDGF-BB secreted by preosteoclasts induces CD31hiEmcnhi vessel subtype in coupling osteogenesis , 2014, Nature Medicine.
[9] M C Sogayar,et al. Bone Morphogenetic Proteins , 2014, Journal of dental research.
[10] M. Viñas,et al. Risk factors for denture-related oral mucosal lesions in a geriatric population. , 2014, The Journal of prosthetic dentistry.
[11] Y. Tabata,et al. Gelatin hydrogel carrier with the W9-peptide elicits synergistic effects on BMP-2-induced bone regeneration , 2013 .
[12] Chunyan Li,et al. Adrenomedullin delivery in microsphere-scaffold composite for remodeling of the alveolar bone following tooth extraction: an experimental study in the rat , 2013, Biomedical engineering online.
[13] E. Hurwitz,et al. Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis. , 2013, The Journal of bone and joint surgery. American volume.
[14] N. Wakabayashi,et al. The influence of mechanical stimulation on osteoclast localization in the mouse maxilla: bone histomorphometry and finite element analysis , 2013, Biomechanics and modeling in mechanobiology.
[15] K. Aoki,et al. The local administration of TNF-α and RANKL antagonist peptide promotes BMP-2-induced bone formation , 2013 .
[16] J. Penninger,et al. Stimulation of Bone Formation in Cortical Bone of Mice Treated with a Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-binding Peptide That Possesses Osteoclastogenesis Inhibitory Activity , 2013, The Journal of Biological Chemistry.
[17] J. Kanis,et al. Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[18] K. Aoki,et al. Peptide-based delivery to bone. , 2012, Advanced drug delivery reviews.
[19] K. Aoki,et al. A structural modulator of tumor necrosis factor type 1 receptor promotes bone formation under lipopolysaccharide-induced inflammation in a murine tooth extraction model. , 2012, European journal of pharmacology.
[20] M. Wong,et al. A systematic review of post-extractional alveolar hard and soft tissue dimensional changes in humans. , 2012, Clinical oral implants research.
[21] D. Kim,et al. Human buccal plate extraction socket regeneration with recombinant human platelet-derived growth factor BB or enamel matrix derivative. , 2011, The International journal of periodontics & restorative dentistry.
[22] M. E. Corrêa,et al. Clinical and histomorphometric evaluation of extraction sockets treated with an autologous bone marrow graft. , 2010, Clinical oral implants research.
[23] Yasuhiko Tabata,et al. Bone Regeneration Using a Bone Morphogenetic Protein-2 Saturated Slow-Release Gelatin Hydrogel Sheet: Evaluation in a Canine Orbital Floor Fracture Model , 2010, Annals of plastic surgery.
[24] In Gwun Jang,et al. Computational simulation of simultaneous cortical and trabecular bone change in human proximal femur during bone remodeling. , 2010, Journal of biomechanics.
[25] Hiroshi Suzuki,et al. Vps33a Mediates RANKL Storage in Secretory Lysosomes in Osteoblastic Cells , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[26] K. Aoki,et al. LPS‐Induced Inhibition of Osteogenesis Is TNF‐α Dependent in a Murine Tooth Extraction Model , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[27] P. Guy,et al. Cortical and trabecular bone in the femoral neck both contribute to proximal femur failure load prediction , 2009, Osteoporosis International.
[28] Shibing Yu,et al. Rapamycin inhibits osteoblast proliferation and differentiation in MC3T3‐E1 cells and primary mouse bone marrow stromal cells , 2008, Journal of cellular biochemistry.
[29] R. Baron,et al. A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis. , 2007, Arthritis and rheumatism.
[30] D. Heath,et al. An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myeloma. , 2007, Cancer research.
[31] Akira Yamaguchi,et al. A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss. , 2006, The Journal of clinical investigation.
[32] S. Glassman,et al. Adverse Effects Associated With High-Dose Recombinant Human Bone Morphogenetic Protein-2 Use in Anterior Cervical Spine Fusion , 2006, Spine.
[33] H. Terai,et al. Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist. , 2005, Bone.
[34] J. Fiorellini,et al. Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. , 2005, Journal of periodontology.
[35] Hiroyuki Nakaya,et al. Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. , 2005, Bone.
[36] T. Griffin,et al. A comparative study of root coverage with connective tissue and platelet concentrate grafts: 8-month results. , 2004, Journal of periodontology.
[37] Hongtao Zhang,et al. Disabling of Receptor Activator of Nuclear Factor-κB (RANK) Receptor Complex by Novel Osteoprotegerin-like Peptidomimetics Restores Bone Loss in Vivo* , 2004, Journal of Biological Chemistry.
[38] T. Kawamoto,et al. Use of a new adhesive film for the preparation of multi-purpose fresh-frozen sections from hard tissues, whole-animals, insects and plants. , 2003, Archives of histology and cytology.
[39] K Ohya,et al. Synergistic effect of fibroblast growth factor-4 in ectopic bone formation induced by bone morphogenetic protein-2. , 2002, Bone.
[40] N. Udagawa,et al. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. , 1999, Biochemical and biophysical research communications.
[41] D. Lacey,et al. Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.
[42] K Yano,et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[43] R. Murali,et al. Structure–based design and characterization of exocyclic peptidomimetics that inhibit TNFα binding to its receptor , 1997, Nature Biotechnology.